Crossmark

Comprehensive genomic analysis identifies pathogenic variants in maturity-onset diabetes of the young (MODY) patients in South India

Crossref DOI link: https://doi.org/10.1186/s12881-018-0528-6

Published Online: 2018-02-13

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mohan, Viswanathan

Radha, Venkatesan

Nguyen, Thong T.

Stawiski, Eric W.

Pahuja, Kanika Bajaj

Goldstein, Leonard D.

Tom, Jennifer

Anjana, Ranjit Mohan

Kong-Beltran, Monica

Bhangale, Tushar

Jahnavi, Suresh

Chandni, Radhakrishnan

Gayathri, Vijay

George, Paul

Zhang, Na

Murugan, Sakthivel

Phalke, Sameer

Chaudhuri, Subhra

Gupta, Ravi

Zhang, Jingli

Santhosh, Sam

Stinson, Jeremy

Modrusan, Zora

Ramprasad, V. L.

Seshagiri, Somasekar http://orcid.org/0000-0003-4272-6443
Peterson, Andrew S.
More Information

Article History

Received: 25 August 2017

Accepted: 19 January 2018

First Online: 13 February 2018

Ethics approval and consent to participate

: Written informed consent was obtained from all the study participants. Consent from the Parents or legal guardian was obtained wherever samples from minors were included in the study. The study was approved by the Institutional Ethics Committee of the Madras Diabetes Research Foundation. The reported investigations have been carried out in accordance with the principles of the Declaration of Helsinki.

: Not applicable

: All Genentech Inc. authors hold shares in Roche.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.